Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by KNOX, E G
Right arrow Articles by SHANNON, H S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KNOX, E G
Right arrow Articles by SHANNON, H S
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 Oxford University Press

research-article

A Model Basis for the Control of Whooping Cough

E G KNOX and H S SHANNON

Department of Social Medicine, University of Birmingham Edgbaston, Birmingham, B15 2TJ, UK

The problems of controlling and ultimately eradicating pertussis are addressed in the face of the apparent impermanence of vaccine immunity, and the limited protection offered while it lasts. Interactions between partial immunity, reduced infectiousness, responses to a superimposed natural infection, changing mean ages of infection and alternative rates of transmission before the vaccine was introduced, are considered in an integrated manner. Mathematical expressions were developed for these different components, from which a computer program was constructed for predicting the levels of control to be expected from different vaccination strategies.

The most important of the parameters determining outcomes are (1) those relating to levels of uptake, (2) the choice of a one-course or two-course policy, and (3) the specification of the vaccine itself. As might be expected, high levels of uptake and a two-course policy are necessary for high levels of control, but they will not necessarily succeed. The detailed specification of the type of protection to be offered by a vaccine is also crucial. The most important necessity is for a vaccine immunity with a low rate of decay; but in the presence of decay (which greatly reduces the feasibility of eradication) it is important that the vaccine should protect against the clinical disease without preventing the child from being infected with the organism, and thus attaining permanent immunity.

Received 1 March 1986


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.